Business context and reporting period
QDRO Acquisition Corp., a Cayman Islands special purpose acquisition company, filed this Form 8-K on April 6, 2026, covering events in connection with its initial public offering (IPO). The report gives March 26, 2026 as the earliest event date, while stating that the IPO was consummated on March 30, 2026.
Key financial and transaction details
- The company sold 20,000,000 units at $10.00 each, for gross IPO proceeds of $200 million. Each unit comprises one Class A ordinary share and one-half of one redeemable warrant.
- The company also sold 6,000,000 private placement warrants for $1.00 each, generating $6 million in gross proceeds.
- $200 million of IPO proceeds, including $12 million of the underwriter’s deferred discount, was placed in a U.S.-based trust account.
- Each whole public warrant is exercisable for one Class A ordinary share at $11.50 per share. The filing does not provide revenue, profit, operating cash flow, margins, or a clear liquidity or debt summary in the supplied text.
Changes, outlook, and risks
This filing reports the IPO and related private placement; it does not provide a comparable prior-period operating update, business guidance, or management outlook. It refers to an audited balance sheet as of March 30, 2026, filed as Exhibit 99.1, but that balance sheet is not included in the supplied text.
The transaction dates are inconsistent: the filing says the IPO closed on March 30, but describes the private placement as occurring on March 26 “simultaneously” with the IPO. The text does not explain the discrepancy.
Facts for investors to verify
- Confirm the IPO closing date and the timing of the private placement against Exhibit 99.1 and other filed transaction documents.
- Review the audited March 30, 2026 balance sheet for cash, trust assets, liabilities, and any other financial details not shown in this filing text.
- Verify the trust-account terms, including the treatment of the $12 million deferred underwriting discount.
- Review the terms and potential dilution associated with the public and private placement warrants.